Cerner (CERN) was right on target with Q2 earnings reported after the close Tuesday, but sales were a bit under expectations and the company lowered its guidance for full-year revenue. Cerner said it expects full-year 2015 revenue of $4.48 billion to $4.58 billion, down from its previous range of $4.65 billion to $4.8 billion and well below Wall Street estimates of $4.72 billion. Adjusted earnings projections were not changed and remained in line
Chipmakers such as Qualcomm and Cypress Semiconductor see healthy growth ahead through the “Internet of Medical Things.” In one example, Qualcomm (QCOM) and health-records software maker Cerner (CERN) are partnering to move health monitoring out of hospitals and into patients’ homes. Cerner uses Qualcomm’s chips to collect data from mobile medical devices and securely transmit the information to doctors and nurses so they can remotely manage
Cerner (CERN) stock fell Wednesday, as Wall Street found little inspiration from the medical software maker’s Q4 earnings posted after the close Tuesday. Cerner logged earnings of 47 cents a share, up 21% from the year-earlier and in line with consensus estimates. Revenue climbed 16% to $926 million, topping views. Bookings rose 5% to $1.16 billion, but bookings had risen 19% in Q3. U.S. revenue rose 14%, while global revenue climbed 34%. The